MRSA

IDSA MRSA Guidelines

IDSA MRSA GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/88040

Contents of this Issue

Navigation

Page 12 of 17

Pediatric Dose (Adult/Child) Class 15 mg/kg/dose IV q6h B-II/A-II B-II/C-III 6-10 mg/kg/dose IV daily 10 mg/kg/dose PO/IV q8h Max: 600 mg/dose 10-13 mg/kg/dose PO/IV q6-8h Max: 40 mg/kg/day No data B-II/C-III B-III/A-II B-III/ND A-II Comments A-II Long-term oral suppressive antibiotics (eg, TMP-SMX, a tetracycline, a fluoroquinolone,¶ or clindamycin) with or without rifampin may be considered in selected cases, particularly if device removal is not possible (B-III). A-II For details please see antibiotic recommendations for device-related osteoarticular infections in full text guidelines at: http://www.idsociety.org/content. aspx?id=4432#mrsa A-II ¶ Due to the potential emergence of fluoroquinolone resistance, particularly if adequate surgical debridement is not possible, it should be given in conjunction with rifampin. 11

Articles in this issue

Links on this page

Archives of this issue

view archives of MRSA - IDSA MRSA Guidelines